GILD [NASD]
Gilead Sciences, Inc.
IndexS&P 500 P/E18.81 EPS (ttm)3.28 Insider Own0.09% Shs Outstand1.26B Perf Week-1.86%
Market Cap78.44B Forward P/E9.53 EPS next Y6.47 Insider Trans0.00% Shs Float1.25B Perf Month-2.80%
Income4.14B PEG- EPS next Q1.55 Inst Own82.60% Short Float1.33% Perf Quarter-1.07%
Sales27.52B P/S2.85 EPS this Y-8.80% Inst Trans0.68% Short Ratio2.47 Perf Half Y3.77%
Book/sh16.11 P/B3.83 EPS next Y-2.60% ROA6.30% Target Price70.78 Perf Year-11.68%
Cash/sh4.45 P/C13.85 EPS next 5Y-1.23% ROE20.00% 52W Range57.17 - 74.12 Perf YTD-15.04%
Dividend2.92 P/FCF13.63 EPS past 5Y-13.10% ROI16.40% 52W High-16.77% Beta0.32
Dividend %4.73% Quick Ratio1.30 Sales past 5Y-2.10% Gross Margin75.60% 52W Low7.92% ATR1.48
Employees14400 Current Ratio1.40 Sales Q/Q0.70% Oper. Margin25.50% RSI (14)40.66 Volatility2.36% 2.25%
OptionableYes Debt/Eq1.30 EPS Q/Q-24.80% Profit Margin15.00% Rel Volume1.30 Prev Close63.07
ShortableYes LT Debt/Eq1.25 EarningsAug 02 AMC Payout87.40% Avg Volume6.76M Price61.69
Recom2.60 SMA20-4.26% SMA50-2.53% SMA200-2.98% Volume8,788,797 Change-2.19%
Jul-13-22Initiated Cantor Fitzgerald Neutral $70
May-23-22Initiated SVB Leerink Mkt Perform $68
Feb-28-22Downgrade BMO Capital Markets Outperform → Market Perform $75 → $65
Feb-02-22Reiterated Wells Fargo Equal Weight $72 → $70
Feb-02-22Reiterated Truist Hold $77 → $75
Feb-02-22Reiterated RBC Capital Mkts Outperform $87 → $85
Feb-02-22Reiterated BofA Securities Neutral $73 → $71
Feb-02-22Reiterated BMO Capital Markets Outperform $85 → $75
Jan-28-22Upgrade Argus Hold → Buy
Jan-06-22Downgrade Morgan Stanley Overweight → Equal-Weight $84 → $74
Dec-09-21Resumed Wells Fargo Equal Weight $72
Dec-06-21Initiated Goldman Neutral $80
Nov-19-21Upgrade BMO Capital Markets Market Perform → Outperform $72 → $85
Nov-19-21Resumed Piper Sandler Neutral $77
Oct-20-21Resumed Cowen Outperform
Jul-30-21Reiterated RBC Capital Mkts Outperform $81 → $84
Jul-30-21Reiterated BMO Capital Markets Market Perform $67 → $72
Apr-01-21Upgrade Bernstein Mkt Perform → Outperform $80
Mar-30-21Upgrade Redburn Neutral → Buy
Jan-19-21Upgrade Morgan Stanley Equal-Weight → Overweight $83
Sep-30-22 09:55AM
Sep-29-22 07:10AM
Sep-28-22 08:12PM
08:00PM
01:00PM
09:02AM Loading…
09:02AM
Sep-27-22 05:50PM
Sep-24-22 09:00AM
Sep-23-22 10:10AM
09:45AM
Sep-22-22 12:17PM
08:30AM
Sep-21-22 05:50PM
01:49PM
Sep-20-22 04:30PM
08:02AM Loading…
08:02AM
Sep-19-22 09:28AM
Sep-16-22 02:58PM
07:04AM
07:00AM
06:56AM
06:39AM
Sep-15-22 06:48PM
06:21PM
05:50PM
01:30PM
09:55AM
Sep-14-22 05:52AM
Sep-13-22 05:44PM
11:28AM
10:48AM Loading…
10:48AM
09:32AM
05:25AM
Sep-12-22 09:08AM
Sep-10-22 02:37PM
08:39AM
Sep-09-22 05:45PM
11:15AM
Sep-08-22 05:50PM
01:27PM
11:53AM
Sep-07-22 06:05PM
06:05PM
01:15PM
12:37PM
11:30AM
08:45AM
Sep-06-22 06:30PM
03:05PM
10:16AM
Sep-04-22 06:05PM
Sep-03-22 06:08AM
Sep-02-22 05:45PM
11:31AM
Sep-01-22 11:31AM
Aug-31-22 09:00AM
Aug-30-22 11:51AM
Aug-29-22 04:05PM
08:30AM
Aug-25-22 10:23AM
Aug-24-22 09:57AM
Aug-22-22 11:57AM
01:00AM
Aug-19-22 08:45AM
Aug-18-22 09:55AM
Aug-17-22 12:15PM
11:00AM
Aug-16-22 01:10PM
12:08PM
08:45AM
Aug-15-22 07:15PM
05:29PM
04:42PM
04:28PM
03:06PM
10:20AM
08:30AM
Aug-11-22 08:45AM
Aug-10-22 05:13AM
Aug-09-22 10:00AM
09:45AM
07:50AM
Aug-07-22 10:45AM
Aug-04-22 12:13PM
09:55AM
09:31AM
08:00AM
Aug-03-22 05:40PM
04:04PM
03:46PM
12:12PM
11:51AM
10:58AM
09:53AM
06:14AM
Aug-02-22 11:00PM
05:25PM
04:34PM
04:01PM
Aug-01-22 01:59PM
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of liver diseases. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of hematology, oncology, and cell therapy patients. In addition, the company provides Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; Ranexa, an oral formulation for the treatment of chronic angina; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Gadeta B.V.; Bristol-Myers Squibb Company; Dragonfly Therapeutics, Inc.; and Merck & Co, Inc. The company was incorporated in 1987 and is headquartered in Foster City, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lofton Kevin EDirectorApr 28Option Exercise25.6216,322418,25190,525Apr 29 06:43 PM
Pletcher Brett AEVP,Corp Affairs & Gen CounselMar 11Sale58.243,634211,64432,576Mar 14 09:46 PM
Mercier JohannaChief Commercial OfficerMar 10Option Exercise0.006,987037,765Mar 14 09:14 PM
O'Day Daniel PatrickChairman & CEOMar 10Option Exercise0.0024,0030260,396Mar 14 09:52 PM
Wilfong Diane E.SVP, Controller & CAOMar 10Option Exercise0.003,297027,516Mar 14 09:30 PM
Pletcher Brett AEVP,Corp Affairs & Gen CounselFeb 09Sale63.891,691108,03832,576Feb 11 02:57 PM
Dickinson Andrew DChief Financial OfficerFeb 06Option Exercise0.001,817060,473Feb 08 08:25 PM
Pletcher Brett AEVP,Corp Affairs & Gen CounselFeb 06Option Exercise0.002,727035,303Feb 08 08:24 PM
Wilfong Diane E.SVP, Controller & CAOFeb 06Option Exercise0.001,864024,739Feb 08 08:22 PM
Pletcher Brett AEVP,Corp Affairs & Gen CounselFeb 01Sale68.5414,061963,68232,576Feb 02 06:37 PM